is metformin a glp 1 New aspects of an old drug: as glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia Metformin vs Ozempic: What's the

When a new prescription drug enters the market, the question for employers isnt just does it work? Its what does covering it mean for our people, our plan, and our longterm costs? That question became especially relevant in early 2026, when an oral version of Wegovy entered the market with widespread media coverage

Difference in muscle metabolism caused by metabolism disorder of rainbow trout liver exposed to ammonia stress

Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation

An endurance athlete might end up lighter but weaker, which is clearly not the outcome you want